IDEX Biometrics ASA
IDXAD
$0.001
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 44.09% | 19.82% | 21.93% | 18.47% | 23.76% |
| Total Depreciation and Amortization | 11.33% | 70.55% | 26.76% | 20.93% | -1.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -500.83% | -16.97% | -74.88% | -53.40% | -61.96% |
| Change in Net Operating Assets | 121.60% | 19.49% | 30.92% | -31.31% | -1,462.21% |
| Cash from Operations | 40.42% | 24.09% | 21.99% | 13.91% | 7.31% |
| Capital Expenditure | 85.67% | 75.77% | -27.78% | 2.25% | -38.94% |
| Sale of Property, Plant, and Equipment | 1,216.67% | 1,216.67% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -51.44% | -33.19% | 2.51% | 130.84% | 167.03% |
| Cash from Investing | 684.91% | 413.13% | -7,300.00% | 102.50% | 60.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -883.52% | -760.17% | -503.74% | -67.50% | 32.83% |
| Issuance of Common Stock | -60.39% | -67.96% | -0.46% | -0.72% | -14.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -39.20% | -45.11% | 49.16% | 59.02% | -14.40% |
| Foreign Exchange rate Adjustments | -55.00% | 64.29% | 87.69% | 105.00% | 130.08% |
| Miscellaneous Cash Flow Adjustments | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Net Change in Cash | 52.21% | -65.70% | 76.08% | 72.93% | -39.22% |
